Bad for MSB share price in the short run. Good for humanity, and not going to negate the need for Remestemcel-L for ARDs from Covid and other causes. Anyone seriously looking at this stock for the medium to long term has nothing to worry about, IMO. DYOR
MSB Trading 2020 - a new dawn, page-9910
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
-0.015(1.59%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 92.3¢ | $380.8K | 409.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 115543 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 114669 | 21 |
View Market Depth
| Last trade - 10.58am 09/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |